Norbert W. Bischofberger
2012
In 2012, Norbert W. Bischofberger earned a total compensation of $5.4M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $975,800 |
|---|---|
| Option Awards | $1,908,267 |
| Salary | $815,026 |
| Stock Awards | $1,691,293 |
| Other | $7,500 |
| Total | $5,397,886 |
Bischofberger received $1.9M in option awards, accounting for 35% of the total pay in 2012.
Bischofberger also received $975.8K in non-equity incentive plan, $815K in salary, $1.7M in stock awards and $7.5K in other compensation.
Rankings
In 2012, Norbert W. Bischofberger's compensation ranked 1,098th out of 11,487 executives tracked by ExecPay. In other words, Bischofberger earned more than 90.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,098 out of 11,487 | 90th |
Division Manufacturing | 397 out of 4,253 | 91st |
Major group Chemicals And Allied Products | 91 out of 1,203 | 92nd |
Industry group Drugs | 52 out of 925 | 94th |
Industry Biological Products, Except Diagnostic Substances | 6 out of 165 | 96th |
Source: SEC filing on March 27, 2015.
Bischofberger's colleagues
We found four more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2012.